Promoting Diversity for Translational Success
In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like sex, age, species,...
In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like sex, age, species,...
HTX-011 Breakthrough in Pain Management ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved extended-release dual-acting...
It is important to bridge the gap between lab findings and clinical applications using translational models, ensuring effective translation for human...
Understanding Mechanisms Underlying Neuropathic Pain
As the general population continues to age, the economic burden of chronic pain and neurodegenerative diseases is increasing and becoming...
An excerpt from MD Biosciences publication in the Autumn 2022 issue of Göttingen Minipigs Magazine. MD Biosciences operates a neuroscience research...
MD Biosciences lab has an exclusive expertise in pain studies in the pig. Our scientists have developed an acute model and a neuropathic model in...
MDB Scientists recently published a paper titled “Human-like cutaneous neuropathologies associated with a porcine model of peripheral neuritis: a...